Trade Summary

4 days ago, Pieper Steven, serving as See Remarks at Xeris Biopharma Holdings, Inc. (XERS), sold 45,000 shares at $8.52 per share, for a total transaction value of $383,176.20. Following this transaction, Pieper Steven now holds 1,366,053 shares of XERS.

This sale represents a 3.19% decrease in Pieper Steven's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Monday, July 6, 2026 and publicly disclosed via SEC Form 4 filing on Tuesday, July 7, 2026 at 5:11 PM ET, 1 day after the trade was made.

Xeris Biopharma Holdings, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.